Medicare Enrolled
Dr. Samer Othman, MD
Hospitalist Physician · San Luis Obispo, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Othman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Othman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Othman
Dr. Samer Othman is a hospitalist physician in San Luis Obispo, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Othman performed 7,089 Medicare services across 2,864 unique beneficiaries.
Between the years covered by Open Payments, Dr. Othman received a total of $6,240 from 40 pharmaceutical and/or device companies across 260 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospitalist physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Othman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 1% volume in CA
$6,240 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,089
Medicare services
Top 1% in CA for hospitalist physician
2,864
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~473 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,400 | $101 | $450 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
1,871 | $59 | $137 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
502 | $60 | $550 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
357 | $132 | $457 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
356 | $31 | $68 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
338 | $67 | $195 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
212 | $104 | $202 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
203 | $61 | $123 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
107 | $80 | $800 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
103 | $132 | $375 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
92 | $47 | $145 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
84 | $39 | $195 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
78 | $82 | $1,508 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
73 | $108 | $2,375 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
55 | $100 | $317 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
53 | $37 | $565 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
49 | $164 | $505 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
36 | $100 | $1,467 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
26 | $230 | $2,665 |
| Knee nerve block injection with imaging guidance An injection of anesthetic and/or steroid medication into a nerve branch of the knee, performed using imaging guidance to ensure accurate placement. |
21 | $67 | $800 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
19 | $33 | $825 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
17 | $45 | $1,125 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
13 | $30 | $750 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
12 | $103 | $2,152 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
12 | $47 | $1,350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,240
Total received (2018-2024)
Avg $891/year across 7 years
Top 4% in CA for hospitalist physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
260
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,240 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$576
2023
$550
2022
$2,256
2021
$793
2020
$557
2019
$903
2018
$604
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$289
Lilly USA, LLC
$45
ABBVIE INC.
$45
Avanos Medical
$32
Boston Scientific Corporation
$31
Abbott Laboratories
$30
SCILEX PHARMACEUTICALS INC.
$26
Pacira Pharmaceuticals Incorporated
$25
PFIZER INC.
$19
Indivior Inc.
$18
VERTEX PHARMACEUTICALS INCORPORATED
$17
Top 3 companies account for 65.7% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$2,235
Medtronic USA, Inc.
$1,242
Amgen Inc.
$234
PFIZER INC.
$215
Horizon Therapeutics plc
$192
Teva Pharmaceuticals USA, Inc.
$188
ABBVIE INC.
$180
PAINTEQ LLC
$157
Almatica Pharma LLC
$149
Scilex Pharmaceuticals Inc.
$143
Boston Scientific Corporation
$140
Biosense Webster, Inc.
$124
SI-BONE, Inc.
$115
Lilly USA, LLC
$96
Baudax Bio Inc.
$79
Janssen Pharmaceuticals, Inc
$62
Novartis Pharmaceuticals Corporation
$60
Nevro Corp.
$56
Supernus Pharmaceuticals, Inc.
$47
GRT US Holding, Inc.
$42
Vertiflex, Inc.
$40
BioDelivery Sciences International, Inc.
$37
Avanos Medical
$32
DePuy Synthes Sales Inc.
$32
Abbott Laboratories
$30
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$30
Bioventus LLC
$29
Alnylam Pharmaceuticals Inc.
$29
SCILEX PHARMACEUTICALS INC.
$26
Pacira Pharmaceuticals Incorporated
$25
Alexion Pharmaceuticals, Inc.
$23
Vertos Medical, Inc.
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
Kowa Pharmaceuticals America, Inc.
$18
Indivior Inc.
$18
VERTEX PHARMACEUTICALS INCORPORATED
$17
IBSA Pharma Inc.
$17
Lundbeck LLC
$15
AbbVie Inc.
$14
Forte Bio-Pharma LLC
$13
Top 3 companies account for 59.5% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · AJOVY · ANJESO · ASCENDA · Aimovig · Andexxa · BELBUCA · BUNAVAIL 2.1 mg 30-count box · Carto 3 System · DUEXIS · EMBEDA · EMGALITY · EVENITY · Exparel · GENERAL - PAIN MANAGEMENT · GENERAL - THERAPIES · GENVISC 850 SODIUM HYALURONATE · GIVLAARI · GRALISE · INTELLIS · INTELLIS ADAPTIVESTIM · KYPHON EXPRESS II KYPHOPAK TRAY · LICART · LYRICA · NALOCET · NAPRELAN · NURTEC ODT · ORTHOVISC · PAINTEQ · PENNSAID · PERSERIS · PROCLAIM · QULIPTA · Qutenza · RAYOS · RELISTOR · RESTORE · SPECTRA WAVEWRITER · SYNCHROMED · SYNCHROMEDII · Seglentis · Senza · Senza Spinal Cord Stimulation System · Supartz · Superion ISS · Superion Indirect Decompression System · TROKENDI XR · UBRELVY · VANTA ADAPTIVESTIM · VYEPTI · XARELTO · ZTLido · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for hospitalist physician in CA.
Geographic Context
Hospitalist physicians within 10 mi
6
Per 100K population
2.1
County median income
$93,398
Nearest hospital
ADVENTIST HEALTH SIERRA VISTA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Othman is a clinical cardiology specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 4% of CA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Othman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Othman performed 2,400 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Othman receive payments from pharmaceutical companies?
Yes. Dr. Othman received a total of $6,240 from 40 companies across 260 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Othman's costs compare to other hospitalist physicians in San Luis Obispo?
Dr. Othman's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Othman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hospitalist Physicians in San Luis Obispo
Browse hospitalist physicians in San Luis Obispo ranked by procedure volume and transparency data.
Highest volume
Top Hospitalist Physicians in CA
Hospitalist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hospitalist Physicians in CA
Which CA hospitalist physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology